Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE

Load latest

Bharat Immunological & Biologicals Corporation Ltd.

10 May 2023

21.01

-1.45%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Compliance Report under Regulation 24(A) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ending on 31.03.2023.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

10 May 2023

21.01

-1.45%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Compliance Certificate Under Regulation 7(3) Of Securities …

BSE India

Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is submitted the Certificate duly signed by M/s MAS Services Ltd, Share Transfer Agent and the Company Secretary of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) for the year ending on 31.03.2023 for information and record please

pdf

Bharat Immunological & Biologicals Corporation Ltd.

27 Apr 2023

21.01

-1.45%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Certificate From Practicing Company Secretary Under Regulation …

BSE India

In pursuance of Regulation 40 (9) of the LODR with Stock Exchange, please find attached the Certificate from Practicing Company Secretary for the year ended 31st March 2023.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

17 Apr 2023, 03:33PM

21.01

-1.45%

Board Meeting

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Update on board meeting

BSE India

The Board Meeting to be held on 24/04/2023 has been revised to 24/04/2023 The Board Meeting to be held on 24/04/2023 has been revised to 24/04/2023

pdf

Bharat Immunological & Biologicals Corporation Ltd.

17 Apr 2023, 03:28PM

21.01

-1.45%

Board Meeting

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Board Meeting Intimation for Intimation Of Date …

BSE India

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2023 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 24th April 2023, to approve the annual financial results of the Company for the year ended 31st March 2023.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

10 Feb 2023

21.01

-1.45%

Result

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Submission Of Unaudited Quarterly Financial Results For …

BSE India

In compliance of SEBI LODR with Stock Exchange, please find enclosed the Unaudited Quarterly Financial Results for the quarter and nine months ended December 2022 along with Limited Review Report, approved by the Board of the Company in its Meeting held on 09.02.2023.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

01 Feb 2023

21.01

-1.45%

Board Meeting

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Board Meeting Intimation for Intimation Of Date …

BSE India

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 09th February 2023, to approve the financial results of the Company for the quarter ended 31st December 2022.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

27 Dec 2022

21.01

-1.45%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Clarification sought from Bharat Immunologicals & Biologicals Corporation Ltd

BSE India

The Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on December 27, 2022, with reference to Movement in Price.The reply is awaited.

Bharat Immunological & Biologicals Corporation Ltd.

17 Oct 2022, 05:36PM

21.01

-1.45%

Result

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Board Meeting Outcome for Submission Of Un-Audited …

BSE India

In pursuance of the SEBI LODR, please find attached the Un-audited Quarterly Financial Results for the quarter ended September 2022 and Limited Review Report thereon as per the Compliance of LODR 2015

pdf

Bharat Immunological & Biologicals Corporation Ltd.

11 Oct 2022

21.01

-1.45%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Statement Of Investor Complaints For The Quarter Ended September 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SANDIP KUMAR LALDesignation :- Company Secretary and Compliance Officer

Is Bharat Immunological & Biologicals Corporation Ltd. worth buying?

135 Votes:

Buy 69.63%

Sell 14.81%

Hold 15.56%